Arbor Rapha Capital Bioholdings I (Arbor Rapha Capital Bioholdings I) Total Assets : $179.18 Mil (As of Sep. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Arbor Rapha Capital Bioholdings I Total Assets?

Arbor Rapha Capital Bioholdings I's Total Assets for the quarter that ended in Sep. 2022 was $179.18 Mil.

Total Assets is connected with ROA %. Arbor Rapha Capital Bioholdings I's annualized ROA % for the quarter that ended in Sep. 2022 was 0.78%. Total Assets is also linked to Revenue through Asset Turnover. Arbor Rapha Capital Bioholdings I's Asset Turnover for the quarter that ended in Sep. 2022 was 0.00.

Arbor Rapha Capital Bioholdings I Total Assets Historical Data

The historical data trend for Arbor Rapha Capital Bioholdings I's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arbor Rapha Capital Bioholdings I Total Assets Chart

Arbor Rapha Capital Bioholdings I Annual Data

Trend

Dec21

Total Assets

178.89

Arbor Rapha Capital Bioholdings I Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Total Assets	Get a 7-Day Free Trial			0.40	178.89	178.52	178.55	179.18

Arbor Rapha Capital Bioholdings I Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Arbor Rapha Capital Bioholdings I's Total Assets for the fiscal year that ended in Dec. 2021 is calculated as

Total Assets	=	Total Equity (A: Dec. 2021 )	+	Total Liabilities (A: Dec. 2021 )
	=	168.243	+	10.648
	=	178.89

Arbor Rapha Capital Bioholdings I's Total Assets for the quarter that ended in Sep. 2022 is calculated as

Total Assets	=	Total Equity (Q: Sep. 2022 )	+	Total Liabilities (Q: Sep. 2022 )
	=	168.059	+	11.122
	=	179.18

Arbor Rapha Capital Bioholdings I (NAS:ARCK) Total Assets Explanation

Total Assets is connected with ROA %.

Arbor Rapha Capital Bioholdings I's annualized ROA % for the quarter that ended in Sep. 2022 is

ROA %	=	Net Income (Q: Sep. 2022 )	/	( (Total Assets (Q: Jun. 2022 )	+	Total Assets (Q: Sep. 2022 ))	/ count )
	=	1.4	/	( (178.549	+	179.181)	/ 2 )
	=	1.4	/	178.865
	=	0.78 %

Note: The Net Income data used here is four times the quarterly (Sep. 2022) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Arbor Rapha Capital Bioholdings I's Asset Turnover for the quarter that ended in Sep. 2022 is

	Asset Turnover
=	Revenue (Q: Sep. 2022 )	/	( (Total Assets (Q: Jun. 2022 )	+	Total Assets (Q: Sep. 2022 ))	/ count )
=	0	/	( (178.549	+	179.181)	/ 2 )
=	0	/	178.865
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Arbor Rapha Capital Bioholdings I Total Assets Related Terms

Thank you for viewing the detailed overview of Arbor Rapha Capital Bioholdings I's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Arbor Rapha Capital Bioholdings I (Arbor Rapha Capital Bioholdings I) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Arbor Rapha Capital Bioholdings Corp I (NAS:ARCK) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

333 Earle Ovington Boulevard, Suite 900, Uniondale, NY, USA, 11553

Website

https://arcbiocorp.com

Arbor Rapha Capital Bioholdings Corp I is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Executives

Ralph Mack	director	333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
Kevin M. Slawin	director, officer: Chief Strategy Officer	C/O BELLICUM PHARMACEUTICALS, INC., 2130 W. HOLCOMBE BLVD., STE. 800, HOUSTON TX 77030
Ivan Kaufman	director, 10 percent owner, officer: Chief Executive Officer
Arbor Commercial Mortgage Llc	director, 10 percent owner, officer: Chief Executive Officer	333 EARLE OVINGTON BLVD, STE 900, UNIONDALE NY 11553
Paul Elenio	officer: Chief Financial Officer	C/O ARBOR REALTY TRUST, 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
John Natalone	officer: Treasurer	C/O ARBOR REALTY TRUST, INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
William P Connolly	officer: Secretary & Vice President	C/O ARBOR REALTY TRUST INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
Cyrus D. Walker	director	C/O MARIPOSA CAPITAL, LLC, 500 SOUTH POINTE DRIVE, SUITE 240, MIAMI BEACH FL 33139
Arbor Rapha Capital Llc	director, 10 percent owner, officer: Chief Executive Officer	333 EARLE OVINGTON BLVD., SUITE 900, UNIONDALE NY 11553
Avery Modlin	director	C/O ARBOR REALTY TRUST INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553

Arbor Rapha Capital Bioholdings I (Arbor Rapha Capital Bioholdings I) Headlines

From GuruFocus

Arbor Rapha Capital Bioholdings Corp. I Announces the Separate Trading of its Shares of Class A Common Stock and Redeemable Warrants Commencing December 20, 2021

By PRNewswire PRNewswire • 12-17-2021

Arbor Rapha Capital Bioholdings Corp. I Announces Closing of $172.5 Million Initial Public Offering

By PRNewswire PRNewswire • 11-02-2021